Cargando…
In silico analysis reveals PRR11 as a prognostic and oncogenic marker in lung adenocarcinoma
Lung adenocarcinoma (LUAD) is a common lung cancer. Although there are various treatments for LUAD, its prognosis remains poor. Therefore, it is imperative to identify new targets and develop novel therapeutic strategies. In this study, we analyze the expression of proline rich 11 (PRR11) in pan can...
Autores principales: | Hu, Ankang, Tang, Kaicheng, Liu, Jing, Han, Xufeng, Chen, Quangang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219720/ https://www.ncbi.nlm.nih.gov/pubmed/37233443 http://dx.doi.org/10.1097/MD.0000000000033755 |
Ejemplares similares
-
Comprehensive characterization of MUC16 mutations in lung adenocarcinoma for immunotherapies and prognosis: An observational study
por: Liu, Tingjun, et al.
Publicado: (2023) -
PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric Cancer
por: Song, Zongchang, et al.
Publicado: (2015) -
Lysosome-related genes: A new prognostic marker for lung adenocarcinoma
por: Hu, Zeyang, et al.
Publicado: (2023) -
C-terminal binding protein-2 is a prognostic marker for lung adenocarcinomas
por: Li, Binfeng, et al.
Publicado: (2020) -
Concurrent Oncogene Mutation Profile in Chinese Patients With Stage Ib Lung Adenocarcinoma
por: Wen, Ying-Sheng, et al.
Publicado: (2014)